ES433002A1 - Procedimiento de extraccion de compuestos activos de tipo plasminogeno. - Google Patents
Procedimiento de extraccion de compuestos activos de tipo plasminogeno.Info
- Publication number
- ES433002A1 ES433002A1 ES433002A ES433002A ES433002A1 ES 433002 A1 ES433002 A1 ES 433002A1 ES 433002 A ES433002 A ES 433002A ES 433002 A ES433002 A ES 433002A ES 433002 A1 ES433002 A1 ES 433002A1
- Authority
- ES
- Spain
- Prior art keywords
- compounds
- pulps
- placental
- plasminogen
- obtaining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7345289A FR2254316B1 (es) | 1973-12-18 | 1973-12-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES433002A1 true ES433002A1 (es) | 1976-09-01 |
Family
ID=9129388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES433002A Expired ES433002A1 (es) | 1973-12-18 | 1974-12-17 | Procedimiento de extraccion de compuestos activos de tipo plasminogeno. |
Country Status (14)
Country | Link |
---|---|
US (1) | US4115551A (es) |
JP (1) | JPS6042207B2 (es) |
AU (1) | AU508321B2 (es) |
BE (1) | BE823522A (es) |
CA (1) | CA1046406A (es) |
CH (1) | CH626808A5 (es) |
DE (1) | DE2459915C3 (es) |
DK (1) | DK144023C (es) |
ES (1) | ES433002A1 (es) |
FR (1) | FR2254316B1 (es) |
GB (1) | GB1495289A (es) |
IE (1) | IE40555B1 (es) |
NL (1) | NL183462C (es) |
SE (1) | SE431613B (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2347048A2 (fr) * | 1976-04-07 | 1977-11-04 | Choay Sa | Compositions constituees par des composes du type plasminogene, notamment d'origine placentaire, procede d'obtention des ces compositions, et medicaments contenant ces compositions |
CH635748A5 (fr) * | 1977-08-16 | 1983-04-29 | Cellorgan Laboratoires Sa | Procede d'obtention de cellules placentaires de brebis. |
JPH0310563Y2 (es) * | 1986-06-25 | 1991-03-15 | ||
US5204447A (en) * | 1988-11-14 | 1993-04-20 | Zymogenetics, Inc. | Purification of factor xiii |
AU1191001A (en) * | 1999-10-07 | 2001-05-10 | Human Genome Sciences, Inc. | Plasminogen-like polynucleotides, polypeptides, and antibodies |
US6969515B2 (en) * | 1999-11-13 | 2005-11-29 | Talecris Biotherapeutics, Inc. | Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
US6964764B2 (en) * | 1999-11-13 | 2005-11-15 | Talecris Biotherapeutics, Inc. | Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin |
US7544500B2 (en) * | 1999-11-13 | 2009-06-09 | Talecris Biotherapeutics, Inc. | Process for the production of a reversibly inactive acidified plasmin composition |
US6355243B1 (en) * | 1999-11-13 | 2002-03-12 | Bayer Corporation | Method of thrombolysis by local delivery of active plasmin |
US20030134794A1 (en) * | 2001-11-20 | 2003-07-17 | Madison Edwin L. | Nucleic acid molecules encoding serine protease 17, the encoded polypeptides and methods based thereon |
US8617863B2 (en) * | 2008-06-04 | 2013-12-31 | Grifols Therapeutics Inc. | Composition, method, and kit for preparing plasmin |
PT2403865E (pt) | 2009-03-03 | 2015-11-18 | Grifols Therapeutics Inc | Métodos de preparação de plasminogénio |
TWI801331B (zh) | 2015-11-03 | 2023-05-11 | 美商波麥堤克生物治療股份有限公司 | 纖維蛋白溶酶原缺乏症之纖維蛋白溶酶原替代療法 |
KR20210119428A (ko) * | 2019-01-24 | 2021-10-05 | 프리비파하르마, 컨설팅 게엠베하 | 미세혈전증의 치료 및 예방을 위한 플라스미노겐 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL120993C (es) * | 1962-08-31 | |||
US3234106A (en) * | 1962-12-03 | 1966-02-08 | Cutter Lab | Soluble, purified profibrinolysin and fibrinolysin and method of producing same |
FR1448028A (fr) * | 1964-03-20 | 1966-08-05 | Ile D Etudes Et De Brevets Nov | Procédé pour l'extraction de plasminogène à partir de sérum ou de plasma sanguins |
DE2057041C3 (de) * | 1970-11-20 | 1973-12-20 | Duerkoppwerke Gmbh, 4800 Bielefeld | Vorrichtung zum Stapeln flexibler Arbeitsstücke |
-
1973
- 1973-12-18 FR FR7345289A patent/FR2254316B1/fr not_active Expired
-
1974
- 1974-12-13 CA CA215,976A patent/CA1046406A/en not_active Expired
- 1974-12-14 AU AU76534/74A patent/AU508321B2/en not_active Expired
- 1974-12-17 DK DK657074A patent/DK144023C/da not_active IP Right Cessation
- 1974-12-17 GB GB54444/74A patent/GB1495289A/en not_active Expired
- 1974-12-17 ES ES433002A patent/ES433002A1/es not_active Expired
- 1974-12-17 US US05/533,631 patent/US4115551A/en not_active Expired - Lifetime
- 1974-12-17 IE IE2600/74A patent/IE40555B1/xx unknown
- 1974-12-18 DE DE2459915A patent/DE2459915C3/de not_active Expired
- 1974-12-18 JP JP49145532A patent/JPS6042207B2/ja not_active Expired
- 1974-12-18 SE SE7415963A patent/SE431613B/xx not_active IP Right Cessation
- 1974-12-18 BE BE151650A patent/BE823522A/xx not_active IP Right Cessation
- 1974-12-18 CH CH1683374A patent/CH626808A5/fr not_active IP Right Cessation
- 1974-12-18 NL NLAANVRAGE7416522,A patent/NL183462C/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SE7415963L (es) | 1975-06-19 |
NL183462C (nl) | 1988-11-01 |
BE823522A (fr) | 1975-06-18 |
DE2459915B2 (de) | 1980-06-19 |
FR2254316B1 (es) | 1977-04-22 |
DK144023B (da) | 1981-11-23 |
JPS50116611A (es) | 1975-09-12 |
SE431613B (sv) | 1984-02-20 |
JPS6042207B2 (ja) | 1985-09-20 |
FR2254316A1 (es) | 1975-07-11 |
CH626808A5 (es) | 1981-12-15 |
GB1495289A (en) | 1977-12-14 |
DK144023C (da) | 1982-05-03 |
NL7416522A (nl) | 1975-06-20 |
AU7653474A (en) | 1976-06-17 |
NL183462B (nl) | 1988-06-01 |
CA1046406A (en) | 1979-01-16 |
AU508321B2 (en) | 1980-03-20 |
US4115551A (en) | 1978-09-19 |
IE40555L (en) | 1975-06-18 |
DE2459915C3 (de) | 1986-06-19 |
DE2459915A1 (de) | 1975-06-26 |
DK657074A (es) | 1975-08-25 |
IE40555B1 (en) | 1979-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES433002A1 (es) | Procedimiento de extraccion de compuestos activos de tipo plasminogeno. | |
ES8800050A1 (es) | Un procedimiento para la preparacion de derivados de cetona electrofilicos activados de sustratos de peptidasa, utiles en la inhibicion de enzimas proteasas | |
Gramse et al. | Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. Characterization and effects on blood coagulation in vitro. | |
ES8701783A1 (es) | Procedimiento para la fabricacion de derivados peptidos analogos de la pepstatina. | |
ATE44533T1 (de) | Hemmen von enzymen. | |
NO843002L (no) | Vandig loesning inneholdende en lipid-loeselig farmasoeytisk substans | |
MX166783B (es) | Procedimiento de preparacion de compuestos heterociclicos aromaticos | |
NO963499L (no) | Hydroksaminsyre- og karboksylsyrederivater, fremgangsmåte for deres fremstilling og anvendelse derav | |
FI960073A (fi) | Proteiinien erottaminen | |
DK375588D0 (da) | Methylenphosphonalkylphosphinsyreforbindelser og farmaceutiske sammensaetninger indeholdende samme | |
NO903944D0 (no) | Fremgangsmaate for fremstilling av nye peptidase og isomerase-inhibitorer. | |
MX9305784A (es) | N-(aceilaminometil) glutaril amino acidos. | |
DE69410254D1 (de) | Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente | |
DE69031271D1 (de) | Varianten von pai-2 | |
ATE129525T1 (de) | Verfahren zur bestimmung der aktivität von serinproteasen oder serinproteaseninhibitoren. | |
ES2001863A6 (es) | Procedimiento para la fabricacion de derivados aminoalcoholes peptidicos que contienen un atomo de carbono tetrasubstituido, inhibidores de la renina y de las proteasas acidas | |
FR2688499B1 (fr) | Procede de preparation de la beta-phenylisoserine et de ses analogues. | |
ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
DE3160757D1 (en) | Amino acid and peptide esters of leuco-indo anilines, process for their preparation and agents containing these compounds for the detection of proteolytic enzymes | |
ES2002015A6 (es) | Un procedimiento para la preparacion de nuevos acidos y esteres ((((3-piridinil)metilen)amino)oxi)alcanoicos. | |
Matsumura et al. | Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC | |
BG90414A (bg) | 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им | |
Lukasiewicz et al. | In Vitro Studies on the Mechanism of the Antifibrino-lytic Action of E-Aminocaproic Acid (EACA) | |
ATA261387A (de) | Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung | |
HUT34950A (en) | Process for the production of alpha-allene-alpha-amino acids and of therapeutic preparations containing such agents |